Literature DB >> 11043953

Mapping of functional domains on the influenza A virus RNA polymerase PB2 molecule using monoclonal antibodies.

M Hatta1, Y Asano, K Masunaga, T Ito, K Okazaki, T Toyoda, Y Kawaoka, A Ishihama, H Kida.   

Abstract

Monoclonal antibodies against the PB2 of A/Puerto Rico/8/34 (A/PR/ 8/34) (H1N1) were prepared in order to define the functional domains of the RNA polymerase of influenza virus. The fifteen monoclonal antibodies that were generated were divided into 4 groups on the basis of ELISA binding to PB2 or its peptide fragments. Six Group I antibodies that bound to the PB2 N-terminal region (amino acids 1-104) did not inhibit transcription by the viral ribonucleoprotein complex. A single Group II antibody recognizing the region of amino acids 206-259 inhibited ApG-primed transcription. Groups III and IV antibodies bound to the C-terminal region of amino acids 660-759. Of these, Group III antibodies inhibited transcription. The present results identify multiple monoclonal antibody binding domains in PB2, two of which, when bound by antibodies, negatively affect viral RNA transcription.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11043953     DOI: 10.1007/s007050070068

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  9 in total

1.  Replication-incompetent influenza A viruses that stably express a foreign gene.

Authors:  Makoto Ozawa; Sylvia T Victor; Andrew S Taft; Shinya Yamada; Chengjun Li; Masato Hatta; Subash C Das; Emi Takashita; Satoshi Kakugawa; Eileen A Maher; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  J Gen Virol       Date:  2011-08-31       Impact factor: 3.891

2.  Influenza A virus polymerase inhibits type I interferon induction by binding to interferon beta promoter stimulator 1.

Authors:  Atsushi Iwai; Takuya Shiozaki; Taro Kawai; Shizuo Akira; Yoshihiro Kawaoka; Ayato Takada; Hiroshi Kida; Tadaaki Miyazaki
Journal:  J Biol Chem       Date:  2010-08-10       Impact factor: 5.157

3.  Mutations in the PA Protein of Avian H5N1 Influenza Viruses Affect Polymerase Activity and Mouse Virulence.

Authors:  Gongxun Zhong; Mai Quynh Le; Tiago J S Lopes; Peter Halfmann; Masato Hatta; Shufang Fan; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

4.  Compatibility among polymerase subunit proteins is a restricting factor in reassortment between equine H7N7 and human H3N2 influenza viruses.

Authors:  Chengjun Li; Masato Hatta; Shinji Watanabe; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

5.  Identification of a Novel Viral Protein Expressed from the PB2 Segment of Influenza A Virus.

Authors:  Seiya Yamayoshi; Mariko Watanabe; Hideo Goto; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

6.  Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air.

Authors:  Neal Van Hoeven; Claudia Pappas; Jessica A Belser; Taronna R Maines; Hui Zeng; Adolfo García-Sastre; Ram Sasisekharan; Jacqueline M Katz; Terrence M Tumpey
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-11       Impact factor: 11.205

7.  Heat shock protein 70 modulates influenza A virus polymerase activity.

Authors:  Rashid Manzoor; Kazumichi Kuroda; Reiko Yoshida; Yoshimi Tsuda; Daisuke Fujikura; Hiroko Miyamoto; Masahiro Kajihara; Hiroshi Kida; Ayato Takada
Journal:  J Biol Chem       Date:  2014-01-28       Impact factor: 5.157

8.  Rapid and highly informative diagnostic assay for H5N1 influenza viruses.

Authors:  Nader Pourmand; Lisa Diamond; Rebecca Garten; Julianna P Erickson; Jochen Kumm; Ruben O Donis; Ronald W Davis
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

9.  G Protein Pathway Suppressor 1 Promotes Influenza Virus Polymerase Activity by Activating the NF-κB Signaling Pathway.

Authors:  Tomoko Kuwahara; Seiya Yamayoshi; Takeshi Noda; Yoshihiro Kawaoka
Journal:  mBio       Date:  2019-12-17       Impact factor: 7.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.